Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Serine-Threonine Kinase Inhibitors
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
97
194
291
388
485
582
679
776
873
970
sorafenib
/ Generic mfg.
everolimus
/ Generic mfg.
sirolimus
/ Generic mfg.
Ibrance
(palbociclib) / Pfizer
Stivarga
(regorafenib) / Bayer
Votrient
(pazopanib) / Novartis, BeiGene
Xience
(everolimus-eluting stent) / Abbott
Epidaza
(chidamide) / Chipscreen
Torisel
(temsirolimus) / Pfizer
Verzenio
(abemaciclib) / Eli Lilly
Tafinlar
(dabrafenib) / Novartis, BeiGene
Zelboraf
(vemurafenib) / Roche
Kisqali
(ribociclib) / Novartis
Viracept
(nelfinavir) / ViiV Healthcare, Roche
Resolute ZES
(zotarolimus-eluting stent) / Medtronic
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
Braftovi
(encorafenib) / Ono Pharma, Pierre Fabre, Pfizer
Zepsun
(donafenib) / Suzhou Zelgen
ingenol mebutate
/ Generic mfg.
Lumakras
(sotorasib) / Amgen
dordaviprone
(ONC201) / Chimerix
Absorb
(everolimus-eluting bioresorbable vascular scaffold) / Abbott
Turalio
(pexidartinib) / Daiichi Sankyo
Cosela
(trilaciclib) / G1 Therap
niclosamide
/ Generic mfg.
LY3295668
/ Eli Lilly
